Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


A compound found in cashew nuts shell called anacardic acid has been found to promote myelin repair and lessen neuronal damage and disability in a study on mice. A research team from Vanderbilt...
Further evidence that the Epstein-Barr virus (EBV) may cause multiple sclerosis (MS) comes in the form of a new study from Germany in which all 901 early disease patients were carrying antibodies...
Data from France has shown that for people with multiple sclerosis (MS), high scores on the expanded disability severity scale (EDSS), age, and obesity were linked as risk factors to more severe...
A new study has identified a possible biomarker in the blood that may help predict the severity and progression of MS. High levels of neurofilament light chain (NfL) was linked to higher disability...
Just four weeks of mindfulness meditation could help to improve emotional balance and thinking ability in people with multiple sclerosis (MS), and even more so than cognitive training, new research...
Half of people with radiologically isolated syndrome (RIS) will go on to develop multiple sclerosis (MS), according to a new study. RIS is a phenomenon where MS-like damage shows up on an MRI but the...
A new study has found that disability seems to accumulate in people with relapsing remitting multiple sclerosis (MS) in a progressive way, rather than as a direct result of relapses. To get these...
Vulnerable and at-risk groups, including some people with multiple sclerosis (MS) will soon be able to spend time outside their homes, the Health and Social Care Secretary has announced. From Monday...
A new study has found the risk of a relapse for someone with relapsing remitting multiple sclerosis (RRMS) switching from Tysabri (natalizumab) to another injectable or oral after two or more years...
Have you ever dreamed of completing a marathon? Well, this July you could do just that, as here at MS-UK, we’ve launched the UK’s most accessible marathon, in which anyone can take part regardless of...

Pages